L. S. Snegireva

Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis

Mikhail M. Kostik, M. F. Dubko, V.V. Masalova et al. · Seminars in Arthritis and Rheumatism · 2014 · 48 citations

Medicine, Clinical Sciences, Immunology +15

Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study

Mikhail M. Kostik, L.V. Bregel, Ilia S. Avrusin et al. · Frontiers in Pediatrics · 2021 · 47 citations · Full text

Medicine, Internal Medicine, Pediatrics +13

The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience

Mikhail M. Kostik, Rinat K. Raupov, Evgeny N. Suspitsin et al. · Frontiers in Pediatrics · 2022 · 34 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17

Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.

Mikhail M. Kostik, E. Gaidar, Alla Y. Hynnes et al. · PubMed · 2016 · 28 citations

Medicine, Pediatrics, Pharmacotherapy +17

Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data

Mikhail M. Kostik, L.V. Bregel, Ilia S. Avrusin et al. · Frontiers in Pediatrics · 2022 · 22 citations · Full text

Medicine, Cardiology, Pediatrics +14